Previously, we and other groups have reported that EAAT1 and EAAT2 are decreased in PD animal models and PD patients, and glutamate excitotoxicity mediated by dysfunctional glutamate transporters in astrocytes contributes to the pathogenesis of PD25,32–34. Here, SLC1A2 is linked to Parkinson disease.